Similarly, higher nuclear CBLL1 was significantly associated with a smaller tumour size, lower Ki67 labelling index, PR positivity and HER2 negativity, as well as histological tumour types of a more favourable prognosis (p < 0.0001; Table 1). This evidence concerns the gene ERBB2 and neoplasm.